The role of Inflammatory Processes in Occurrence of Left Ventricular Failure in Patients with Chronic Kidney Disease

Document Type : Original Article

Authors
Hassan Shemirani 1
Sara Tavakol 1
Abdolamir Atapoor 2
Jafar Golshahi 1
1 Interventional Cardiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Recently, the relationship between increased level of inflammatory mediators and occurrence of left ventricular failure in patients with kidney disease has been suggested. The present study attempted to assess relationship between inflammatory mediators and occurrence of left ventricular failure in patients with chronic kidney disease. Materials and Methods: This cross-sectional study was performed at Noor and Hazrat Aliasghar hospital in Isfahan between September 2012 to September 2013 on patients aged >19 years that referred for following their chronic kidney disease. Serum level of inflammatory parameters including C-reactive protein (CRP) and Interleukin-6 (IL-6) was measured using spectrophotometer. All patients were also assessed using M-mode echocardiography to determine left ventricular ejection fraction (LVEF). Results: The group with significant reduced LVEF showed lower GFR when compared to the normal LVEF group (40.73 ± 20.61% versus 44.43 ± 17.98%, P = 0.032). Comparing GFR across the three groups with normal LVEF >55%), with mild LV dysfunction (LVEF: 45 – 55) those with significant LV dysfunction (LVEF < 45%) showed significantly lower GFR level in latter group compared with normal LVEF and mild LV dysfunction group (P = 0.026). Although the level of serum CRP was significantly higher in patients with significant left ventricular failure than other groups (P = 0.018). Conclusion: Inflammatory processes can potentially affect left ventricular function in patients with chronic kidney disease. In this regard, increased level of CRP may be a main factor for predicting severity of left ventricular failure in these patients.

Keywords

1.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47.  Back to cited text no. 1
    
2.
Ramirez SP, McClellan W, Port FK, Hsu SI. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 2002;13:1907-17.  Back to cited text no. 2
    
3.
Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007;11:156-63.  Back to cited text no. 3
    
4.
US Renal Data Systems. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.  Back to cited text no. 4
    
5.
Ansell D, Feest T, Hodsman A, Rao R. UK Renal Registry, The Renal Associaton, The Ninth Annual Report. Bristol, UK: UK Renal Registry; 2006.  Back to cited text no. 5
    
6.
Lamb EJ. United Kingdom guidelines for chronic kidney disease. Scand J Clin Lab Invest Suppl 2008;241:16-22.  Back to cited text no. 6
    
7.
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.  Back to cited text no. 7
    
8.
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(Suppl 3):S112-9.  Back to cited text no. 8
    
9.
London GM. Left ventricular hypertrophy: Why does it happen? Nephrol Dial Transplant 2003;18(Suppl 8):viii2-6.  Back to cited text no. 9
    
10.
U.S. Renal Data System, USRDS 2006 Annual data report. Bethesda (MD): NIH, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.  Back to cited text no. 10
    
11.
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995;7:884-90.  Back to cited text no. 11
    
12.
Malik J, Tuka V, Mokrejsova M, Holaj R, Tesar V. Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res 2009;58:613-21.  Back to cited text no. 12
    
13.
Rasic S, Kulenovic I, Haracic A, Catovic A. Left ventricular hypertrophy and risk factors for its development in uraemic patients. Bosn J Basic Med Sci 2004;4:34-40.  Back to cited text no. 13
    
14.
Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: Findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004;147:42-8.  Back to cited text no. 14
    
15.
Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation 2003;108:2317-22.  Back to cited text no. 15
    
16.
Wu CK, Yang CY, Lin JW, Hsieh HJ, Chiu FC, Chen JJ, et al. The Relationship Among Central Obesity, Systemic Inflammation, and Left Ventricular Diastolic Dysfunction as Determined by Structural Equation Modeling. Obesity (Silver Spring) 2012;20:730-7.  Back to cited text no. 16
    
17.
Kovesdy CP, Kalantar-Zadeh K. Do genes allow inflammation to kill or not to kill? J Am Soc Nephrol 2009;20:1429-31. Available at:https://www.uptodate.com/contents/inflammation-in-renal-insufficiency. [Last access on 2014 May 02].  Back to cited text no. 17
    
18.
Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-76.  Back to cited text no. 18
    
19.
Erten Y, Tulmac M, Derici U, Pasaoglu H, Altok RK, Bali M, et al. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients. Ren Fail 2005;27:581-9.  Back to cited text no. 19
    
20.
Cottone S, Nardi E, Mule G, Vadala A, Lorito MC, Riccobene R, et al. Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol 2007;67:209-16.  Back to cited text no. 20
    
21.
Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: A large population-based study. BMC Public Health 2009;9:44.  Back to cited text no. 21
    
22.
Fenga C, Cacciola A, Martino LB, Calderaro SR, Di NC, Verzera A, et al. Relationship of blood lead levels to blood pressure in exhaust battery storage workers. Ind Health 2006;44:304-9.  Back to cited text no. 22
    
23.
Libby P, Braunwald E. Braunwald's heart disease: A textbook of cardiovascular medicine. Amsterdam, Netherlands: Elsevier Saunders; 2007.  Back to cited text no. 23
    
24.
Keller C, Katz R, Cushman M, Fried LF, Shlipak M. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol 2008;9:9.  Back to cited text no. 24
    
25.
Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, Whincup PH. Renal function and cardiovascular mortality in elderly men: The role of inflammatory, procoagulant, and endothelial biomarkers. E Heart J 2006;27:2975-81.  Back to cited text no. 25
Advanced Biomedical Research
Volume 2017, February
February 2017
Pages 1-4